Table of Contents

• What is Ribociclib?
• How Ribociclib Works
• Conditions Treated with Ribociclib
• Dosage and Administration
• Potential Side Effects
• Ongoing Research and Future Applications

What is Ribociclib?

Ribociclib, also known by its brand name Kisqali® or research code LEE011, is a medication used primarily in the treatment of certain types of breast cancer^[1]. It belongs to a class of drugs called CDK4/6 inhibitors, which work by blocking specific proteins involved in cell division^[2].

How Ribociclib Works

Ribociclib works by inhibiting two important proteins in our cells called CDK4 and CDK6. These proteins play a crucial role in controlling how cells divide and grow. By blocking these proteins, ribociclib can help slow down or stop the growth of cancer cells^[3].

The medication specifically targets a pathway in cells known as the Rb-E2F pathway. This pathway is often overactive in cancer cells, causing them to multiply rapidly. By interfering with this pathway, ribociclib can help control the spread of cancer^[4].

Conditions Treated with Ribociclib

Ribociclib is primarily used to treat:

• Breast Cancer: Specifically, it’s used for advanced or metastatic breast cancer that is hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-)^[2]. This means the cancer cells have receptors for hormones like estrogen or progesterone, but don’t have too many HER2 proteins.
• Liposarcoma: Some studies are investigating the use of ribociclib in treating well-differentiated or dedifferentiated liposarcoma, a type of soft tissue cancer^[5].
• Brain Tumors: Research is ongoing to evaluate the effectiveness of ribociclib in treating certain types of brain tumors, including glioblastoma and meningioma^[4].

Dosage and Administration

Ribociclib is typically taken orally in the form of tablets. The dosage and schedule can vary depending on the specific condition being treated and individual patient factors. However, some common dosing regimens include:

• 600 mg once daily for 21 days, followed by 7 days off treatment in 28-day cycles^[2].
• 400 mg or 600 mg once daily for 21 days, followed by 7 days off treatment in 28-day cycles^[6].

It’s important to note that ribociclib is often used in combination with other medications, such as hormone therapies like fulvestrant or aromatase inhibitors^[2].

Potential Side Effects

Like all medications, ribociclib can cause side effects. Some of the potential side effects include:

• Decreased white blood cell count (neutropenia)
• Nausea and vomiting
• Fatigue
• Diarrhea
• Hair loss
• Liver function abnormalities

Your healthcare team will monitor you closely for these side effects and may adjust your dosage or provide supportive care as needed^[7].

Ongoing Research and Future Applications

Researchers are continually studying ribociclib to understand its full potential and explore new applications. Some areas of ongoing research include:

• Early-stage Breast Cancer: Studies are investigating the use of ribociclib in combination with endocrine therapy for patients with early high-risk HR+HER2- breast cancer^[6].
• Brain Tumors: Researchers are exploring how well ribociclib can penetrate the blood-brain barrier and its effectiveness against certain brain tumors^[4].
• Combination Therapies: Various studies are looking at combining ribociclib with other medications to enhance its effectiveness or expand its use to other types of cancers^[8].

As research continues, our understanding of ribociclib and its potential applications in cancer treatment will likely expand, potentially offering new hope for patients with various types of cancer.